Journalist

Park Sae-jin
Park Sae-jin박세진
Assistant EditorForeign embassies in Seoul & Geopolitics, Diplomacy, Policy
Experienced journalist and editor at AJU PRESS specializing in multilingual news. I cover international diplomacy, geolpolitics, and policy, consistently delivering highly accurate, compelling reporting for a worldwide audience. "Reporting the facts. Shaping the narrative. Every second counts."
S. Korean broadcaster wins final copyright suit against Chinas video platform Bilibili S. Korean broadcaster wins final copyright suit against China's video platform Bilibili

S. Korean broadcaster wins final copyright suit against China's video platform Bilibili

Kookmin University holds industry seminar on robot skin research Kookmin University holds industry seminar on robot skin research

Kookmin University holds industry seminar on robot skin research

Kim Hyo-joo captures Founders Cup title to reclaim throne after 11 years Kim Hyo-joo captures Founders Cup title to reclaim throne after 11 years

Kim Hyo-joo captures Founders Cup title to reclaim throne after 11 years

Scientists turn toxic gas into medical tool using electric signals Scientists turn toxic gas into medical tool using electric signals

Scientists turn toxic gas into medical tool using electric signals

Im Sung-jae finishes fourth at Valspar as Fitzpatrick claims victory Im Sung-jae finishes fourth at Valspar as Fitzpatrick claims victory

Im Sung-jae finishes fourth at Valspar as Fitzpatrick claims victory

BTS Live: Orderly fan exit caps Gwanghwamun concert BTS Live: Orderly fan exit caps Gwanghwamun concert

BTS Live: Orderly fan exit caps Gwanghwamun concert

[UPDATE] BTS Live: K-pop legend reclaims global spotlight [[UPDATE]] BTS Live: K-pop legend reclaims global spotlight

[[UPDATE]] BTS Live: K-pop legend reclaims global spotlight

BTS Live: Global fans brave biting winds to witness K-pop legends Seoul comeback BTS Live: Global fans brave biting winds to witness K-pop legend's Seoul comeback

BTS Live: Global fans brave biting winds to witness K-pop legend's Seoul comeback

Animuscure receives FDA orphan drug designation for ALS treatment candidate Animuscure receives FDA orphan drug designation for ALS treatment candidate

Animuscure receives FDA orphan drug designation for ALS treatment candidate

BTS Live D-1: Leader RM injured ahead of landmark Seoul comeback BTS Live D-1: Leader RM injured ahead of landmark Seoul comeback

BTS Live D-1: Leader RM injured ahead of landmark Seoul comeback